Surmodics Inc
SRDX35.455USD
-0.575-1.60%
Horário de mercado （ET）Cotações atrasadas em 15 min
506.97MValor de mercado
PerdaP/L TTM
Mais detalhes de Surmodics Inc Empresa
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Informações da empresa
Código da empresaSRDX
Nome da EmpresaSurmodics Inc
Data de listagemMar 04, 1998
CEOMr. Gary R. Maharaj
Número de funcionários389
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 04
Endereço9924 W 74th St
CidadeEDEN PRAIRIE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal55344
Telefone19525007000
Sitehttps://www.surmodics.com/
Código da empresaSRDX
Data de listagemMar 04, 1998
CEOMr. Gary R. Maharaj
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gary R. Maharaj
Mr. Gary R. Maharaj
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
192.06K
-2.07%
Mr. Timothy J. Arens
Mr. Timothy J. Arens
Chief Financial Officer, Senior Vice President - Finance and Information Technology
Chief Financial Officer, Senior Vice President - Finance and Information Technology
67.30K
-1.84%
Mr. Joseph J. Stich
Mr. Joseph J. Stich
Senior Vice President of Human Resources, President - In Vitro Diagnostics
Senior Vice President of Human Resources, President - In Vitro Diagnostics
59.53K
-1.71%
Mr. Charles W. Olson
Mr. Charles W. Olson
Senior Vice President, President - Medical Device Coatings
Senior Vice President, President - Medical Device Coatings
52.28K
-1.80%
Dr. David R. Dantzker, M.D.
Dr. David R. Dantzker, M.D.
Independent Director
Independent Director
40.18K
+2.71%
Ms. Susan E. (Sue) Knight
Ms. Susan E. (Sue) Knight
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
37.24K
+5.95%
Mr. Jose H. Bedoya
Mr. Jose H. Bedoya
Independent Director
Independent Director
30.01K
+3.63%
Mr. Gordon S. Weber, J.D.
Mr. Gordon S. Weber, J.D.
Senior Vice President - Legal, General Counsel, Secretary
Senior Vice President - Legal, General Counsel, Secretary
21.04K
-1.49%
Ms. Lisa Wipperman Heine
Ms. Lisa Wipperman Heine
Independent Director
Independent Director
13.98K
+3.90%
Ms. Teryl L.W. Sides
Ms. Teryl L.W. Sides
Senior Vice President, President - Vascular Interventions
Senior Vice President, President - Vascular Interventions
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gary R. Maharaj
Mr. Gary R. Maharaj
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
192.06K
-2.07%
Mr. Timothy J. Arens
Mr. Timothy J. Arens
Chief Financial Officer, Senior Vice President - Finance and Information Technology
Chief Financial Officer, Senior Vice President - Finance and Information Technology
67.30K
-1.84%
Mr. Joseph J. Stich
Mr. Joseph J. Stich
Senior Vice President of Human Resources, President - In Vitro Diagnostics
Senior Vice President of Human Resources, President - In Vitro Diagnostics
59.53K
-1.71%
Mr. Charles W. Olson
Mr. Charles W. Olson
Senior Vice President, President - Medical Device Coatings
Senior Vice President, President - Medical Device Coatings
52.28K
-1.80%
Dr. David R. Dantzker, M.D.
Dr. David R. Dantzker, M.D.
Independent Director
Independent Director
40.18K
+2.71%
Ms. Susan E. (Sue) Knight
Ms. Susan E. (Sue) Knight
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
37.24K
+5.95%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
Domestic
104.64M
83.00%
Foreign
21.43M
17.00%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qui, 17 de jul
Atualizado em: qui, 17 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
7.32%
AllianceBernstein L.P.
5.94%
The Vanguard Group, Inc.
5.59%
Soleus Capital Management, L.P.
5.52%
Gabelli Funds, LLC
5.03%
Other
70.61%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
7.32%
AllianceBernstein L.P.
5.94%
The Vanguard Group, Inc.
5.59%
Soleus Capital Management, L.P.
5.52%
Gabelli Funds, LLC
5.03%
Other
70.61%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
38.66%
Investment Advisor
23.46%
Hedge Fund
22.11%
Individual Investor
3.88%
Research Firm
3.84%
Bank and Trust
0.51%
Sovereign Wealth Fund
0.22%
Pension Fund
0.11%
Insurance Company
0.03%
Other
7.18%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
318
12.56M
87.87%
-3.96M
2025Q1
343
12.58M
88.00%
-4.09M
2024Q4
362
12.66M
88.58%
-3.97M
2024Q3
348
12.66M
88.74%
-3.48M
2024Q2
329
13.91M
98.26%
-1.49M
2024Q1
308
13.31M
93.49%
-1.66M
2023Q4
311
13.68M
96.13%
-630.83K
2023Q3
314
12.98M
91.82%
-1.55M
2023Q2
312
12.97M
91.74%
-1.29M
2023Q1
318
13.21M
93.54%
-785.00K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
1.05M
7.32%
+6.42K
+0.62%
Mar 31, 2025
AllianceBernstein L.P.
849.35K
5.94%
-161.91K
-16.01%
Mar 31, 2025
The Vanguard Group, Inc.
798.67K
5.59%
-4.62K
-0.58%
Mar 31, 2025
Soleus Capital Management, L.P.
789.06K
5.52%
+50.00K
+6.77%
Mar 31, 2025
Gabelli Funds, LLC
719.00K
5.03%
+105.85K
+17.26%
Mar 31, 2025
Hudson Bay Capital Management LP
464.97K
3.25%
+164.97K
+54.99%
Mar 31, 2025
Morgan Stanley Investment Management Inc. (US)
428.97K
3%
+236.16K
+122.48%
Mar 31, 2025
Qube Research & Technologies Ltd
389.19K
2.72%
-64.84K
-14.28%
Mar 31, 2025
State Street Global Advisors (US)
362.24K
2.53%
-11.29K
-3.02%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
First Trust Merger Arbitrage ETF
2.59%
SPDR S&P Health Care Equipment ETF
0.39%
Inspire Small/Mid Cap ESG ETF
0.19%
iShares Micro-Cap ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
iShares U.S. Medical Devices ETF
0.05%
Franklin US Small Cap Multifactor Index ETF
0.05%
iShares Russell 2000 Growth ETF
0.03%
Proshares Ultra Russell 2000
0.02%
ProShares Hedge Replication ETF
0.02%
Ver Mais
First Trust Merger Arbitrage ETF
Proporção2.59%
SPDR S&P Health Care Equipment ETF
Proporção0.39%
Inspire Small/Mid Cap ESG ETF
Proporção0.19%
iShares Micro-Cap ETF
Proporção0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.08%
iShares U.S. Medical Devices ETF
Proporção0.05%
Franklin US Small Cap Multifactor Index ETF
Proporção0.05%
iShares Russell 2000 Growth ETF
Proporção0.03%
Proshares Ultra Russell 2000
Proporção0.02%
ProShares Hedge Replication ETF
Proporção0.02%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
